Budesonide + formoterol delivered via Spiromax ® for the management of asthma and COPD: The potential impact on unscheduled healthcare costs of improving inhalation technique compared with Turbuhaler ®-Reference-Cited by-同舟云学术

Budesonide + formoterol delivered via Spiromax ® for the management of asthma and COPD: The potential impact on unscheduled healthcare costs of improving inhalation technique compared with Turbuhaler ®

Published:2017-08 Issue: Volume:129 Page:179-188
ISSN:0954-6111
Container-title:Respiratory Medicine
language:en
Short-container-title:Respiratory Medicine

Author:

Lewis A.,Torvinen S.,Dekhuijzen P.N.R.,Chrystyn H.,Melani A.,Zöllner Y.,Kolbe K.,Watson A.T.,Blackney M.,Plich A.

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine

Reference78 articles.

1. European lung white book;European Respiratory Society,2013

2. Validity of two common asthma-specific quality of life questionnaires: juniper mini asthma quality of life questionnaire and Sydney asthma quality of life questionnaire;Apfelbacher;Health Qual. Life Outcomes,2012

3. Factors associated with health-related quality of life in adults with asthma. A cross-sectional study;Gonzalez-Barcala;Multidiscip. Respir. Med.,2012

4. Health-related quality of life is related to COPD disease severity;Stahl;Health Qual. Life Outcomes,2005

5. Management, and Prevention of COPD. Global Initiative for Chronic Obstructive Lung Disease;Global strategy for diagnosis,2015

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Economic evaluations of chronic obstructive pulmonary disease pharmacotherapy: how well are the real-world issues of medication adherence, comorbidities and adverse drug-reactions addressed?;Expert Opinion on Pharmacotherapy;2021-01-13

2. General Practitioner Use of Generically Substitutable Inhaler Devices and the Impact of Training on Device Mastery and Maintenance of Correct Inhaler Technique;Pulmonary Therapy;2020-10-10

3. Device use errors with soft mist inhalers: A global systematic literature review and meta-analysis;Chronic Respiratory Disease;2020-01-01

4. Bronchodilator Efficacy of a Single-Dose 12/400-µg Formoterol/Budesonide Combination as a Dry Powder for Inhalation Delivered by Discair® in Adult Patients with Moderate-to-Severe Stable COPD: Open-Label, Single-Arm, Phase IV Trial;Clinical Drug Investigation;2019-07-23

5. What to consider before prescribing inhaled medications: a pragmatic approach for evaluating the current inhaler landscape;Therapeutic Advances in Respiratory Disease;2019-01